Letter to the Editor: Non-specific effects resulting from use of tocilizumab in mice

Metabolism. 2020 Aug:109:154281. doi: 10.1016/j.metabol.2020.154281. Epub 2020 May 28.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Animals
  • Antibodies, Monoclonal, Humanized
  • Diabetes Mellitus*
  • Diabetic Nephropathies*
  • Inflammasomes
  • Mice
  • Receptors, Interleukin-6

Substances

  • Antibodies, Monoclonal, Humanized
  • Inflammasomes
  • Receptors, Interleukin-6
  • tocilizumab